Eprosartan Mesylate (Mylan Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Eprosartan Mesylate drug offered from Mylan Pharmaceuticals Inc.. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Pharmaceuticals Inc.
NON-PROPRIETARY NAME: eprosartan mesylate
SUBSTANCE NAME: EPROSARTAN MESYLATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2011-12-20
END MARKETING DATE: 0000-00-00


Eprosartan Mesylate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionEprosartan Mesylate from Mylan Pharmaceuticals Inc.
LABELER NAME: Mylan Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 600(mg/1)
START MARKETING DATE: 2011-12-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0378-6629_e7c67baa-202a-416c-8938-43f542027c56
PRODUCT NDC: 0378-6629
APPLICATION NUMBER: ANDA202012

Other EPROSARTAN MESYLATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Mylan Pharmaceuticals Inc.Eprosartan Mesylate